Evaluation of ceftazidime in the treatment of severe infection.
Ten seriously ill patients with infections caused by multiply-resistant organisms were treated with intravenous ceftazidime. Nine showed clinical and bacteriological improvement. Apart from one patient who developed a mild transienterythematous rash, no side effects or toxicity was found.